TheraRadar
Clinical-Stage Companies / Chong Kun Dang

Chong Kun Dang

Pre-Approval PRO BETA
228
Total Trials
24
Phase 3
13
Phase 2
8
Recruiting
1025
Score

Pipeline by Phase

Phase 3
24
Phase 2
13
Phase 1
167

Therapeutic Focus

Hypertension Hypertension and Dyslipidemia Healthy Dyslipidemias Type 2 Diabetes Mellitus

Clinical Trials (228)

NCT06643819 Phase 3 RECRUITING

Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A

Started: 10/14/2024

NCT06916793 Phase 3 NOT YET RECRUITING

A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia

Started: 4/30/2025

NCT05566028 Phase 3 COMPLETED

The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 Diabetes

Started: 10/12/2022

NCT05931224 Phase 3 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy

Started: 6/28/2023

NCT06121518 Phase 3 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy

Started: 7/31/2023

NCT03739125 Phase 3 COMPLETED

Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes

Started: 11/7/2017

NCT04312698 Phase 3 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of CKD-386

Started: 8/29/2019

NCT04255589 Phase 3 COMPLETED

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495

Started: 1/6/2020

NCT04548427 Phase 3 COMPLETED

Study to Evaluate the Efficacy and Safety of CKD-352

Started: 9/22/2020

NCT04857177 Phase 3 COMPLETED

A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration

Started: 10/19/2018

NCT02651870 Phase 3 COMPLETED

Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

Started: 4/22/2015

NCT03583905 Phase 3 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet

Started: 4/4/2018

NCT03431623 Phase 3 COMPLETED

CKD-11101 Phase 3 SC Study

Started: 5/1/2015

NCT03428594 Phase 3 COMPLETED

CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis

Started: 6/1/2015

NCT03246880 Phase 3 COMPLETED

Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients

Started: 9/1/2015

NCT02498509 Phase 3 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of CKD-342

Started: 5/1/2015

NCT02586311 Phase 3 COMPLETED

CKD-330 Phase 3 Trial in Amlodipine Non-responder

Started: 1/1/2016

NCT02451098 Phase 3 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of CKD-391

Started: 3/1/2015

NCT01756430 Phase 3 COMPLETED

Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension

Started: 12/1/2012

NCT01001611 Phase 3 COMPLETED

An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus

Started: 10/1/2009

NCT01634295 Phase 3 COMPLETED

Efficacy and Safety of CKD-828 to Stage 2 Hypertension

Started: 7/1/2012

NCT01106131 Phase 3 COMPLETED

Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin

Started: 5/1/2010

NCT01501253 Phase 3 COMPLETED

CKD-828 S-Amlodipine Non-Responder Trial

Started: 8/1/2011

NCT01426100 Phase 3 COMPLETED

CKD-828 Telmisartan Non-Responder Trial

Started: 8/1/2011

NCT06954766 Phase 2 COMPLETED

Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981

Started: 4/28/2025

NCT05677438 Phase 2 COMPLETED

A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia

Started: 12/20/2022

NCT04628143 Phase 2 COMPLETED

A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia

Started: 12/21/2020

NCT04623021 Phase 2 COMPLETED

A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia

Started: 9/25/2020

NCT03726853 Phase 2 COMPLETED

The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497

Started: 5/29/2018

NCT04204603 Phase 2 COMPLETED

A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate

Started: 11/30/2018

NCT01497873 Phase 2 COMPLETED

A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer

Started: 9/1/2010

NCT02977065 Phase 2 COMPLETED

To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors

Started: 3/23/2017

NCT03437785 Phase 2 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet

Started: 1/16/2018

NCT01630018 Phase 2 COMPLETED

Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial

Started: 1/1/2011

NCT01022671 Phase 2 COMPLETED

Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy

Started: 9/1/2009

NCT01128322 Phase 2 COMPLETED

CKD-828 Primary Hypertension Trial(Dose-selection)

Started: 7/1/2010

NCT07439094 Phase 1 RECRUITING

A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer

Started: 4/16/2026

NCT07215637 Phase 1 RECRUITING

Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors

Started: 10/16/2025

NCT07358156 Phase 1 RECRUITING

A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.

Started: 2/9/2026

NCT07258745 Phase 1 RECRUITING

Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants

Started: 11/26/2025

NCT07532148 Phase 1 NOT YET RECRUITING

Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Started: 6/1/2026

NCT06979973 Phase 1 COMPLETED

A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participants

Started: 5/14/2025

NCT06727396 Phase 1 COMPLETED

A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants

Started: 11/14/2024

NCT07404735 Phase 1 NOT YET RECRUITING

A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

Started: 2/23/2026

NCT06110923 Phase 1 COMPLETED

A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

Started: 11/13/2023

NCT07304687 Phase 1 COMPLETED

Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy Volunteers

Started: 10/24/2025

NCT07304700 Phase 1 COMPLETED

Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/10/1000mg in Healthy Volunteers

Started: 10/28/2025

NCT07304726 Phase 1 COMPLETED

Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers

Started: 10/30/2025

NCT06695572 Phase 1 COMPLETED

Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers

Started: 11/6/2024

NCT06758661 Phase 1 COMPLETED

Clinical Study to Evaluate Drug-drug Interaction and Safety After Co-administration of D352 and D794 in Healthy Adult Volunteers

Started: 11/27/2024

NCT06695598 Phase 1 COMPLETED

Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy Volunteers

Started: 11/6/2024

NCT06709807 Phase 1 COMPLETED

Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers

Started: 11/8/2024

NCT06652971 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Food Effect of CKD-379

Started: 11/5/2024

NCT06492655 Phase 1 NOT YET RECRUITING

To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers

Started: 7/4/2024

NCT06386328 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Food Effect of CKD-378

Started: 5/3/2024

NCT06483243 Phase 1 COMPLETED

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State.

Started: 4/4/2024

NCT06281132 Phase 1 COMPLETED

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults

Started: 3/22/2024

NCT06399055 Phase 1 COMPLETED

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions

Started: 9/16/2022

NCT06399068 Phase 1 COMPLETED

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions

Started: 9/19/2022

NCT05673369 Phase 1 COMPLETED

Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition

Started: 2/1/2023

NCT06088017 Phase 1 COMPLETED

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)

Started: 10/23/2023

NCT06112678 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)

Started: 1/4/2024

NCT05741437 Phase 1 COMPLETED

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378

Started: 4/11/2023

NCT05928637 Phase 1 COMPLETED

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150

Started: 7/10/2023

NCT04488900 Phase 1 COMPLETED

Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects

Started: 7/6/2020

NCT05921435 Phase 1 COMPLETED

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy Adults

Started: 6/20/2023

NCT04952506 Phase 1 COMPLETED

Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers

Started: 7/19/2021

NCT05897216 Phase 1 COMPLETED

Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029

Started: 7/14/2023

NCT05749861 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)

Started: 4/22/2023

NCT04883658 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)

Started: 6/4/2021

NCT04660370 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348

Started: 1/9/2021

NCT05816759 Phase 1 COMPLETED

Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150

Started: 5/26/2023

NCT05587699 Phase 1 COMPLETED

The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A

Started: 11/15/2022

NCT06204107 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379

Started: 11/21/2023

NCT05881213 Phase 1 COMPLETED

Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults

Started: 6/1/2023

NCT05698043 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg

Started: 7/17/2023

NCT05881707 Phase 1 COMPLETED

A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg

Started: 7/4/2023

NCT05634447 Phase 1 COMPLETED

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391

Started: 12/20/2022

NCT05834595 Phase 1 COMPLETED

A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828

Started: 5/2/2023

NCT05113693 Phase 1 COMPLETED

Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393

Started: 11/25/2021

NCT05549401 Phase 1 COMPLETED

Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348

Started: 9/29/2022

NCT05335044 Phase 1 COMPLETED

Study to Evaluate the Safety and Pharmacokinetics of CKD-331

Started: 5/31/2022

NCT05192356 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)

Started: 2/23/2022

NCT05719155 Phase 1 COMPLETED

Pharmacokinetics and Safety/Tolerability of CKD-379

Started: 2/27/2023

NCT05571813 Phase 1 COMPLETED

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects

Started: 11/2/2022

NCT05544214 Phase 1 COMPLETED

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects

Started: 10/21/2022

NCT05526742 Phase 1 COMPLETED

A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy Subjects

Started: 8/24/2022

NCT05552495 Phase 1 COMPLETED

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions

Started: 9/23/2022

NCT05540912 Phase 1 COMPLETED

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects

Started: 9/15/2022

NCT05207761 Phase 1 COMPLETED

Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930

Started: 1/19/2022

NCT05274880 Phase 1 COMPLETED

Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393

Started: 6/21/2022

NCT05452525 Phase 1 COMPLETED

Pharmacokinetics and Safety/Tolerability Profile of CKD-379

Started: 7/26/2022

NCT05089279 Phase 1 COMPLETED

Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers

Started: 11/3/2021

NCT05189288 Phase 1 COMPLETED

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects

Started: 1/14/2022

NCT05245084 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg

Started: 3/15/2022

NCT04673682 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845

Started: 11/16/2020

NCT05238948 Phase 1 COMPLETED

CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects

Started: 2/28/2022

NCT05347576 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions

Started: 4/21/2022

NCT04746287 Phase 1 COMPLETED

Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects

Started: 1/14/2020

NCT04805606 Phase 1 COMPLETED

A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843

Started: 4/30/2021

NCT04987970 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg

Started: 9/12/2021

NCT04869800 Phase 1 COMPLETED

Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg

Started: 5/27/2021

NCT04830930 Phase 1 COMPLETED

A Study to Investigate the Effect of Food on the PK, PD of CKD-381 in Healthy Volunteers

Started: 4/21/2021

NCT04768673 Phase 1 COMPLETED

A Study to Investigate the PK and Safety of CKD-393

Started: 3/26/2021

NCT04673864 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386

Started: 1/17/2021

NCT04694989 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)

Started: 2/20/2021

NCT04810676 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.

Started: 4/16/2021

NCT04260438 Phase 1 COMPLETED

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects

Started: 4/8/2020

NCT04587206 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348

Started: 10/15/2020

NCT04431687 Phase 1 COMPLETED

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)

Started: 6/15/2020

NCT04334213 Phase 1 COMPLETED

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150

Started: 5/7/2020

NCT04304547 Phase 1 COMPLETED

Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers

Started: 2/4/2020

NCT04258865 Phase 1 COMPLETED

A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348

Started: 3/25/2020

NCT04354987 Phase 1 COMPLETED

Compare the Pharmacokinetics and Safety of CKD-391

Started: 10/30/2019

NCT02631954 Phase 1 COMPLETED

Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers

Started: 9/1/2015

NCT04272502 Phase 1 COMPLETED

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers

Started: 6/4/2019

NCT04083846 Phase 1 COMPLETED

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)

Started: 9/6/2019

NCT04075643 Phase 1 COMPLETED

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers

Started: 9/19/2019

NCT04083872 Phase 1 COMPLETED

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)

Started: 9/6/2019

NCT04019743 Phase 1 COMPLETED

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers

Started: 7/28/2019

NCT03858725 Phase 1 COMPLETED

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers

Started: 2/26/2019

NCT03887871 Phase 1 COMPLETED

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal

Started: 3/11/2019

NCT03887858 Phase 1 COMPLETED

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers

Started: 3/11/2019

NCT03868072 Phase 1 COMPLETED

Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy Volunteers

Started: 2/22/2019

NCT04156685 Phase 1 COMPLETED

Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1

Started: 8/6/2019

NCT03802162 Phase 1 COMPLETED

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355

Started: 2/15/2019

NCT03738449 Phase 1 COMPLETED

The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition

Started: 1/8/2019

NCT03793985 Phase 1 COMPLETED

Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337

Started: 9/5/2018

NCT03616392 Phase 1 COMPLETED

Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308

Started: 7/25/2018

NCT03659149 Phase 1 COMPLETED

Pharmacokinetics and Safety Profile of CKD-333

Started: 8/8/2018

NCT03558425 Phase 1 COMPLETED

A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects

Started: 6/27/2018

NCT03609606 Phase 1 COMPLETED

A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects

Started: 8/9/2018

NCT03671941 Phase 1 COMPLETED

Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy Volunteers

Started: 5/25/2018

NCT03569579 Phase 1 COMPLETED

CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1)

Started: 4/16/2018

NCT03444402 Phase 1 COMPLETED

A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects

Started: 3/2/2018

NCT03382756 Phase 1 COMPLETED

A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337

Started: 10/12/2017

NCT03346187 Phase 1 COMPLETED

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

Started: 5/19/2017

NCT03211143 Phase 1 COMPLETED

A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects

Started: 6/20/2017

NCT02685774 Phase 1 COMPLETED

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers

Started: 2/1/2016

NCT02827890 Phase 1 COMPLETED

CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)

Started: 4/1/2016

NCT02615782 Phase 1 COMPLETED

A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male Subjects

Started: 12/1/2015

NCT02422030 Phase 1 COMPLETED

CKD-337(2) Drug-drug Interaction Study

Started: 3/17/2015

NCT02066207 Phase 1 COMPLETED

CKD-337 Drug Interaction Study

Started: 3/18/2014

NCT02336854 Phase 1 COMPLETED

Tacrobell tab_Phase1_PK

Started: 1/12/2015

NCT03233932 Phase 1 COMPLETED

CKD-841 Pharmacokinetic/Pharmacodynamic Study

Started: 4/1/2016

NCT03034486 Phase 1 COMPLETED

The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930

Started: 2/17/2017

NCT03017950 Phase 1 COMPLETED

Pharmacokinetic Drug-drug Interaction of CKD-330 and D086

Started: 12/1/2016

NCT02753504 Phase 1 COMPLETED

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Started: 4/1/2016

NCT03175835 Phase 1 COMPLETED

Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects

Started: 5/8/2017

NCT03210649 Phase 1 COMPLETED

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Started: 3/7/2017

NCT01684605 Phase 1 COMPLETED

Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers

Started: 10/12/2012

NCT01685671 Phase 1 COMPLETED

Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male Volunteers

Started: 10/26/2012

NCT02916901 Phase 1 COMPLETED

Study to Investigate the Influence of CKD-519 on 24-h Ambulatory Blood Pressure in Healthy Adult Volunteers

Started: 8/1/2016

NCT02894541 Phase 1 COMPLETED

Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519

Started: 8/1/2016

NCT02501200 Phase 1 COMPLETED

CKD-391 Pharmacokinetic Study Phase I

Started: 8/1/2015

NCT02007941 Phase 1 COMPLETED

Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects

Started: 4/1/2014

NCT02461004 Phase 1 COMPLETED

CKD-391 Pharmacokinetic Study

Started: 7/1/2015

NCT01580371 Phase 1 COMPLETED

Safety and Pharmacokinetic Profile of CKD-581

Started: 5/1/2012

NCT02824874 Phase 1 COMPLETED

CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)

Started: 4/1/2016

NCT02651753 Phase 1 COMPLETED

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

Started: 1/1/2016

NCT02005744 Phase 1 COMPLETED

A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function

Started: 3/1/2014

NCT02811731 Phase 1 COMPLETED

Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B

Started: 4/1/2015

NCT02801526 Phase 1 COMPLETED

Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A

Started: 4/1/2015

NCT02648854 Phase 1 COMPLETED

Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers

Started: 10/1/2015

NCT02623868 Phase 1 COMPLETED

Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.

Started: 10/1/2015

NCT02645890 Phase 1 COMPLETED

Study to Compare the Safety and Pharmacokinetics of CKD-397

Started: 11/1/2015

NCT02589457 Phase 1 COMPLETED

Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet

Started: 10/1/2015

NCT02627027 Phase 1 COMPLETED

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers

Started: 8/1/2015

NCT02548286 Phase 1 COMPLETED

Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs

Started: 8/1/2015

NCT02484482 Phase 1 COMPLETED

Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)

Started: 6/1/2015

NCT02565368 Phase 1 COMPLETED

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers

Started: 7/1/2015

NCT01560325 Phase 1 COMPLETED

Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers

Started: 6/1/2012

NCT02156544 Phase 1 COMPLETED

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Started: 6/1/2014

NCT02247505 Phase 1 COMPLETED

CKD-397 Drug-drug Interaction Study (B)

Started: 9/1/2014

NCT02247518 Phase 1 COMPLETED

CKD-397 Drug-drug Interaction Study (A)

Started: 9/1/2014

NCT02358824 Phase 1 COMPLETED

CKD-828 (80/5mg) Pharmacokinetic Study

Started: 2/1/2015

NCT02250833 Phase 1 COMPLETED

CKD-828 (80/5mg) Pharmacokinetic Study

Started: 9/1/2014

NCT02288338 Phase 1 COMPLETED

CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers

Started: 11/1/2014

NCT02186496 Phase 1 COMPLETED

Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)

Started: 7/1/2014

NCT02064621 Phase 1 COMPLETED

CKD-330 Drug-Drug Interaction Study (Candesartan)

Started: 6/1/2014

NCT02064556 Phase 1 COMPLETED

CKD-330 Drug-Drug Interaction Study (Amlodipine)

Started: 5/1/2014

NCT02002611 Phase 1 COMPLETED

Drug-drug Interaction Study(Lobeglitazone, Warfarin)

Started: 12/1/2013

NCT02047175 Phase 1 COMPLETED

CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)

Started: 2/1/2014

NCT01842230 Phase 1 COMPLETED

Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine

Started: 4/1/2013

NCT01842256 Phase 1 COMPLETED

Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.

Started: 4/1/2013

NCT01270984 Phase 1 COMPLETED

Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects

Started: 11/1/2010

NCT01663038 Phase 1 COMPLETED

Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination

Started: 12/1/2010

NCT01369472 Phase 1 COMPLETED

Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule

Started: 6/1/2011

NCT01028859 Phase 1 COMPLETED

Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers

Started: 12/1/2009

NCT01340248 Phase 1 COMPLETED

A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers

Started: 7/1/2011

NCT01496261 Phase 1 COMPLETED

Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial

Started: 8/1/2011

NCT01356017 Phase 1 COMPLETED

CKD-828 Drug Interaction Study (Telmisartan)

Started: 6/1/2011

NCT01356043 Phase 1 COMPLETED

CKD-828 Drug Interaction Study (S-amlodipine)

Started: 5/1/2011

NCT01341392 Phase 1 COMPLETED

Drug-drug Interaction Study(CKD-501, Amlodipine)

Started: 4/1/2011

NCT01330563 Phase 1 COMPLETED

Drug-drug Interaction Study (CKD-501, Ketoconazole)

Started: 3/1/2011

NCT01352689 Phase 1 COMPLETED

CKD-828(80/2.5mg) Pharmacokinetic Study_2nd

Started: 4/1/2011

NCT01340131 Phase 1 COMPLETED

CKD-828 (40/5mg) Pharmacokinetic Study

Started: 1/1/2011

NCT01246193 Phase 1 COMPLETED

CKD-828(80/2.5mg) Pharmacokinetic Study

Started: 11/1/2010

NCT01005160 Phase 1 COMPLETED

Drug Interaction Between CKD-501 and Metformin

Started: 10/1/2009

NCT01019941 Phase 1 COMPLETED

Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer

Started: 8/1/2009

NCT01133431 Phase 1 COMPLETED

The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea

Started: 5/1/2010

NCT01071720 Phase 1 COMPLETED

The Effect of Food on the Pharmacokinetic Characteristics of CKD-501

Started: 3/1/2010

NCT01016626 Phase 1 COMPLETED

Study to Evaluate the Pharmacokinetic Characteristics of CKD-4101 (Mycophenolate Mofetil) Tablet

Started: 7/1/2009

NCT06430047 Phase 4 RECRUITING

Efficacy and Safety of EsoDuo®

Started: 11/25/2022

NCT06431477 Phase 4 RECRUITING

Efficacy and Safety of Telmisartan Compared With Losartan

Started: 4/19/2023

NCT04102943 Phase 4 COMPLETED

Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.

Started: 11/30/2017

NCT06044493 Phase 4 COMPLETED

MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients

Started: 11/14/2023

NCT04471441 Phase 4 COMPLETED

Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients.

Started: 6/30/2020

NCT05193565 Phase 4 ACTIVE NOT RECRUITING

Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients

Started: 11/19/2021

NCT07365358 Phase 4 NOT YET RECRUITING

Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients

Started: 3/1/2026

NCT06942156 Phase 4 NOT YET RECRUITING

Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea

Started: 8/14/2025

NCT03794492 Phase 4 COMPLETED

Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome

Started: 3/31/2018

NCT04539652 Phase 4 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients

Started: 9/20/2018

NCT03749356 Phase 4 COMPLETED

Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients

Started: 9/5/2018

NCT04521023 Phase 4 COMPLETED

A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

Started: 9/20/2017

NCT04511000 Phase 4 COMPLETED

Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg

Started: 10/11/2017

NCT02231788 Phase 4 COMPLETED

The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy

Started: 6/1/2014

NCT03067194 Phase 4 COMPLETED

The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients

Started: 12/27/2016

NCT03928470 Phase 4 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg

Started: 1/29/2019

NCT01756937 Phase 4 COMPLETED

Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee

Started: 1/1/2013

NCT01682564 Phase 4 COMPLETED

To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure

Started: 1/1/2012

NCT01860482 Phase 4 COMPLETED

The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD

Started: 4/1/2013

NCT02356679 Phase 4 COMPLETED

Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients

Started: 8/1/2014

NCT01842269 Phase 4 COMPLETED

Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients

Started: 1/1/2013

NCT01746680 Phase 4 COMPLETED

Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis

Started: 8/1/2012

NCT01743287 Phase 4 COMPLETED

The Study to Evaluate Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee

Started: 12/1/2012

NCT01766505 Phase 4 TERMINATED

The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)

Started: 6/1/2012

NCT01029522 Phase 4 COMPLETED

Dyslipidemia in Cardiovascular Disease

Started: 8/1/2008

Drug Candidates

tacrolimus tablet tacrolimus capsules CKD-215 D215 Myreptic-N Tablet Mycophenolate mofetil Tablet/Capsule Everolimus Tab. Mycophenolate mofetil Tab./Cap. Reference Drug Placebo Drug
Activity Status: Active
Last Trial Started: 6/1/2026
Last Trial Ended: 11/23/2025
Trials (12 months): 12
Completed Trials: 213
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.